Mulligan Therapy Effects In Healthy Subjects With Induced Vertigo
1 other identifier
interventional
30
1 country
2
Brief Summary
This analysis aims to evaluate the immediate effect that cervical sustained natural apophyseal glides (SNAGs) have on a group of individuals with induced vertigo by a caloric vestibular stimulation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2018
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 3, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 4, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 28, 2018
CompletedFirst Submitted
Initial submission to the registry
October 19, 2021
CompletedFirst Posted
Study publicly available on registry
November 12, 2021
CompletedNovember 12, 2021
November 1, 2021
4 months
October 19, 2021
November 3, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
vHIT (Video Head Impulse Test)
Detection of peripheral vestibular deficits and their recovery
15 minutes
Secondary Outcomes (1)
Anxiety
5 minutes
Study Arms (3)
SNAG GROUP
EXPERIMENTALThe SNAG group received a treatment based on sustained apophyseal glides in a postero-anterior direction on C2 with a dose of three series of ten repetitions each, combined with active cervical extension.
SHAM SNAG GROUP
SHAM COMPARATORThe placebo SNAG group received a simulation of the contact used for the SNAGs, without any vertebral glide, and with an active cervical extension.
CONTROL GROUP
NO INTERVENTIONThe control group did not receive any type of intervention, they only waited for four minutes, sat down on a chair
Interventions
It consists on a sustained apophyseal glides in a postero-anterior direction on C2 with a dose of three series of ten repetitions each
Subjects on SNAG group received a simulation of the contact used for the SNAGs, without any vertebral glide, and with an active cervical extension
Eligibility Criteria
You may qualify if:
- Healthy subjects,
- Age 18-44 years.
You may not qualify if:
- Consume of antipsychotics, antidepressants, antiarrythmics and/or anticonvulsivants
- Hippoacusia
- Auditory diseases
- Peripheral or central vestibulopathies
- Cerviogenic dizziness
- Balance disorders
- Nistagmus
- Oculomotor nerve dysfunctions
- Migraine
- Cervical osteoporosis, lashing or fracture
- Discal cervical hernia
- Cervical neuropathy
- Psychriatic disorders
- Epilepsy
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
CSEU La Salle
Madrid, 28023, Spain
Jose V Leon Hernandez
Madrid, 28023, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 19, 2021
First Posted
November 12, 2021
Study Start
February 3, 2018
Primary Completion
June 4, 2018
Study Completion
June 28, 2018
Last Updated
November 12, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share
Data will only be treated by study researchers